SWOT Analysis for Puma Biotechnology Inc - Weakness

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

High Normalized Momentum Score

Strong Momentum: Price above short, medium and long term moving averages

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Affordable Stocks - Stocks with Good Trendlyne Valuation Score

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company reducing Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

Stocks Outperforming their Industry Price Change in the Quarter

MACD Crossover Below Signal Line

PE higher than Industry PE

MACD crossed below signal line previous end of day

Declining Net Cash Flow : Companies not able to generate net cash

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Institutions decreased their shareholding last quarter

Promoters increasing shareholding QoQ

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks